Zobrazeno 1 - 10 of 81 pro vyhledávání: '"Larsolof, Hafström"'
1
[Insurance claims after vascular surgery]
Autor: David, Bergqvist, Larsolof, Hafström, Pelle, Gustafson
Publikováno v: Lakartidningen. 117
Insurance claims after vascular surgery have been analyzed during two three-year periods. Ca 0.6 % of arterial operations and 0.3 % of venous operations have been claimed, 30 % and 40 % respectively having been economically compensated as they were j
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::6a166a36149204e3da54c2086b3162ad
https://pubmed.ncbi.nlm.nih.gov/33320309
Zobrazit plný text záznamu
2
Regional Perfusion With Anticancer Drugs for Treatment of Malignant Tumors
Autor: Per-Ebbe Jönsson, Larsolof Hafström
Publikováno v: Tumor Blood Circulation: Angiogenesis, Vascular Morphology and Blood Flow of Experimental and Human Tumors ISBN: 9780429283024
Tumor Blood Circulation: Angiogenesis, Vascular Morphology and Blood Flow of Experimental and Human Tumors
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b7e597c080e8aa71d44d899b8964c57a
https://doi.org/10.1201/9780429283024-13
Zobrazit plný text záznamu
3
The Consequences of Negligence Claims in Arterial Surgery - An Analysis of Two Periods with an Increasing Use of Endovascular Treatment
Autor: Larsolof Hafström, David Bergqvist, Pelle Gustafson
Publikováno v: European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery. 58(5)
Objectives Patient treatment within the Swedish medical service system can claim negligence injuries to the malpractice insurance review board and request financial compensation. The aim of this paper was to analyse the consequences of a negligence c
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a9512aac325f86befd63a9e3950bea2
https://pubmed.ncbi.nlm.nih.gov/31530500
Zobrazit plný text záznamu
4
Staging and therapy for patients with hepatocellular cancer in a defined population from 2000 to 2011 – active palliative treatment improved overall survival
Autor: Larsolof Hafström, Erik Holmberg, Per Lindnér, Magnus Rizell
Publikováno v: Acta Oncologica. 55:297-302
Sweden's western region has successively introduced the use of validated non-invasive diagnostic algorithms and treatment allocation for hepatocellular cancer (HCC). The aim was to analyse whether between 2000 and 2011 these changes in strategy had a
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6921e4ef50c0e978e213f0927773c8ec
https://doi.org/10.3109/0284186x.2015.1080857
Zobrazit plný text záznamu
5
Risk factors for injuries associated with damage claims following groin hernia repair
Autor: Larsolof Hafström, Henrik Holmberg, Pär Nordin, H. Johansson, J. Ahlberg
Publikováno v: Hernia
Purpose Surgical repair of groin hernia should be carried out with minimal complication rates, and it is important to have regular quality control and accurate means of assessment. The Swedish healthcare system has a mutual insurance company (LÖF) t
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2bfb21552b25674af85f865074f347e8
http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-134823
Zobrazit plný text záznamu
6
Diagnostic delay of breast cancer – An analysis of claims to Swedish Board of Malpractice (LÖF)
Autor: Larsolof Hafström, Henry Johansson, Jon Ahlberg
Publikováno v: The Breast. 20:539-542
Aim Delay in the diagnosis of breast cancer may have important clinical and medico-legal implications. This study examined the decisions made by reviewers at the Swedish agency (LOF) that handles claims of medical malpractice where claimants seek com
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9155c72166dc8406196444ffbb3d79e0
https://doi.org/10.1016/j.breast.2011.06.007
Zobrazit plný text záznamu
7
Type IV collagen as a tumour marker for colorectal liver metastases
Autor: Peter Naredi, Malin Sund, Hanna Nyström, Larsolof Hafström
Publikováno v: European Journal of Surgical Oncology (EJSO). 37:611-617
About 50% of patients with primary colorectal cancer (CRC) will develop liver metastases (CLM). Currently, carcinoembryonic antigen (CEA) is the most common tumour marker for CRC and CLM. However, the sensitivity and specificity of this marker is not
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b15ffba62925968c6215b60b691684e7
https://doi.org/10.1016/j.ejso.2011.04.010
Zobrazit plný text záznamu
8
Prediagnostic Levels of Carcinoembryonic Antigen and CA 242 in Colorectal Cancer: A Matched Case-Control Study
Autor: Boel Engarås, Björn Tavelin, Larsolof Hafström, Sten Hammarström, Gudrun Lindmark, Richard Palmqvist, Göran Hallmans, Olle Nilsson
Publikováno v: Diseases of the Colon & Rectum. 46:1538-1544
PURPOSE: Carcinoembryonic antigen is the classical tumor marker for colorectal cancer. The main clinical utility is in monitoring patients with colorectal cancer. Like carcinoembryonic antigen, the plasma level of CA 242 is elevated in patients with
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eeac139fd95ab46e171c4617587cb7cb
https://doi.org/10.1007/s10350-004-6810-z
Zobrazit plný text záznamu
10
A Systematic Overview of Chemotherapy Effects in Colorectal Cancer
Autor: Peter Ragnhammar, Bengt Glimelius, Larsolof Hafström, Peter Nygren
Publikováno v: Acta Oncologica. 40:282-308
A systematic review of chemotherapy trials in several tumour types was performed by The Swedish Council of Technology Assessment in Health Care (SBU). The procedures for the evaluation of the scientific literature are described separately (Acta Oncol
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fe32f7288341f4a9968a16dddc2a7bd7
https://doi.org/10.1080/02841860151116367
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje